Market Cap
$23.6B
XYL
Xylem Inc.
$102.22 ▲ +1.33%
Prev close $100.88Market cap$23.6B
ConsensusBuy
12-mo target$152.94 (+49.6%)
▲ Bullish
Analyst conviction 7/10
Insider Selling Cluster (2 insiders)26 New Institutional Positions24 Institutional ExitsCongressional Activity (1) Industrials & Manufacturing
Snapshot
The big-picture read on XYL right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (69%)
Inst. Holders
50 funds
Inst. Value
$18.9B
Inst. Activity
26 buys / 24 sells
Insider Activity
$141.1K buy / $501.4K sell
Insider Net $
-$360.3K
Social Sentiment
75° Bullish
SEC Reports
6
Congressional
3 trades
Price chart 30d -4.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 Insider
McShane Geri-Michelle was granted 4,225 shares
SVP, CAO
Oct 1, 2026 short_volume
Short Volume: XYL — 66.1% short (0.9M / 1.3M)
Short: 891,743 | Exempt: 7,262 | TRF Vol: 1,348,641 | Short Ratio: 66.1% | Off-exchange volume (dark
Sep 30, 2026 Event
Sep 15, 2026 SEC HSR Early Termination: Xylem Inc.; Flow Controls Holding, LLC
The FTC granted early termination of the HSR Act waiting period for a transaction involving Xylem In
Xylem is issuing an undisclosed aggregate principal amount of senior notes across three tranches to finance its ~$1.46B
424B5 — Impact 4/10
Sep 1, 2026 Insider
van der Berg Andrea Michele was granted 6,034 shares
EVP & Chief Financial Officer @ $106.89 ($645.0K)
Sep 1, 2026 Insider
Jul 28, 2026 SEC van der Berg Andrea Michele was granted 1,693 shares
EVP & Chief Financial Officer
Xylem reported Q2 2026 adjusted EPS of $1.46, beating consensus of $1.34 by 9%, while revenue of $2.34B was in line. Ful
8-K — Impact 6/10
Jul 7, 2026 Congress
Ro Khanna buy
$1,001 - $15,000 — House
Analyst ratings buy % -1.4%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
69% rate it Buy or better · 26 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 24, 2026 | Jefferies | MAINTAIN | Buy | 53% |
| Aug 13, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Jul 30, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Jul 29, 2026 | Stifel | MAINTAIN | Buy | 54% |
| Jul 29, 2026 | Mizuho | MAINTAIN | Neutral | 52% |
| Jul 29, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Jul 29, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Jul 29, 2026 | Baird | MAINTAIN | Outperform | 54% |
| Jul 20, 2026 | Stifel | MAINTAIN | Buy | 54% |
| Jul 16, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 8 | 10 | 8 | 0 | 0 | 69% | |
| Aug 1, 2026 | 8 | 11 | 9 | 0 | 0 | 68% | |
| Jul 1, 2026 | 8 | 12 | 8 | 0 | 0 | 71% | |
| Jun 1, 2026 | 7 | 11 | 10 | 0 | 0 | 64% | |
| May 1, 2026 | 7 | 11 | 10 | 0 | 0 | 64% | |
| Apr 1, 2026 | 7 | 13 | 8 | 0 | 0 | 71% | |
| Mar 1, 2026 | 7 | 13 | 8 | 0 | 0 | 71% | |
| Feb 1, 2026 | 8 | 12 | 8 | 0 | 0 | 71% |
Price targets
Where 16 covering analysts think XYL trades over the next 12 months.
$152.94 +49.6% upside Strong Buy
Current$102.22 Low$129.00 Median$158.50 High$180.00 16 analysts
$129.00$180.00
Analyst rating Buy· 1.9/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
75°
Bullish
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
6 SEC filing reports analyzed · 0 bullish, 0 bearish, 1 mixed, 5 neutral · avg impact 3.8/10.
NEUTRAL424B54/10
Xylem is issuing an undisclosed aggregate principal amount of senior notes across three tranches to
Sep 15, 2026
MIXED8-K6/10
Xylem reported Q2 2026 adjusted EPS of $1.46, beating consensus of $1.34 by 9%, while revenue of $2.
Jul 28, 2026
NEUTRAL424B53/10
Xylem Inc. filed a preliminary prospectus supplement for a debt offering of senior notes and senior
May 19, 2026
NEUTRALCLUSTER2/10
Insider cluster at Xylem shows mixed activity: a director purchased $141K worth of shares, while an
May 8, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: XYL — 66.1% short (0.9M / 1.3M)
Short: 891,743 | Exempt: 7,262 | TRF Vol: 1,348,641 | Short Ratio: 66.1% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
Enforcement
HSR Early Termination: Xylem Inc.; Flow Controls Holding, LLC
The FTC granted early termination of the HSR Act waiting period for a transaction involving Xylem Inc.; Flow Controls Holding, LLC.
Sep 30, 2026
short_volume
Short Volume: XYL — 61.6% short (0.5M / 0.8M)
Short: 496,802 | Exempt: 0 | TRF Vol: 806,143 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: XYL — 60.6% short (0.6M / 0.9M)
Short: 555,067 | Exempt: 62 | TRF Vol: 915,267 | Short Ratio: 60.6% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: XYL — 63.7% short (0.4M / 0.6M)
Short: 375,158 | Exempt: 1,933 | TRF Vol: 589,192 | Short Ratio: 63.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $1.45 | $1.41–$1.53 | 6.2% | -0.0% | 5↑ 11↓ | $2.3B | 18 |
| Next Q | $1.65 | $1.56–$1.70 | 16.2% | +0.0% | 12↑ 4↓ | $2.5B | 18 |
| Current FY | $5.66 | $5.59–$5.75 | 11.5% | +0.0% | 21↑ 0↓ | $9.2B | 20 |
| Next FY | $6.25 | $5.96–$6.50 | 10.3% | +0.0% | 17↑ 3↓ | $9.6B | 20 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $1.455 | — |
| 7d ago | $1.455 | — |
| 30d ago | $1.455 | -0.000 |
| 60d ago | $1.459 | -0.004 |
| 90d ago | $1.457 | -0.002 |
Institutional ownership
Which big funds own XYL (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $18.9B total value (160,274,631 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 26 institutions added/increased vs 24 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 25,037,896 | $3.0B | 15.6% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 15,533,420 | $1.8B | 9.7% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 12,618,888 | $1.5B | 7.9% | — |
| STATE STREET CORP | 11,444,669 | $1.4B | 7.1% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 6,347,784 | $747.4M | 3.9% | — |
| Amundi | 5,105,298 | $603.6M | 3.2% | — |
| Invesco Ltd. | 5,102,044 | $603.1M | 3.2% | — |
| Bank of New York Mellon Corp | 4,672,304 | $552.3M | 2.9% | DOUBLED +295.1% |
| ROYAL BANK OF CANADA | 4,605,175 | $544.4M | 2.9% | — |
| Impax Asset Management Group plc | 4,468,984 | $528.3M | 2.8% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | DOUBLED | 1,182,460 | 4,672,304 | +295.1% | $552.3M |
| Swedbank AB | TRIM | 5,526,725 | 3,960,515 | -28.3% | $468.2M |
| NORGES BANK | NEW | — | 2,544,452 | — | $300.8M |
| UBS Group AG | ADD | 1,075,083 | 1,433,166 | +33.3% | $169.4M |
| BARCLAYS PLC | ADD | 739,023 | 963,583 | +30.4% | $113.9M |
| FIRST TRUST ADVISORS LP | ADD | 678,971 | 921,253 | +35.7% | $108.9M |
| ABN AMRO Bank N.V. | TRIM | 1,507,466 | 892,400 | -40.8% | $105.5M |
| ABN AMRO INVESTMENT SOLUTIONS | DOUBLED | 370,627 | 854,445 | +130.5% | $101.0M |
| Man Group plc | ADD | 579,441 | 767,383 | +32.4% | $90.7M |
| AMERICAN CENTURY COMPANIES INC | TRIM | 1,300,336 | 723,793 | -44.3% | $85.6M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
21 insiders, 50 transactions. Net -$360.3K — $141.1K bought, $501.4K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | McShane Geri-Michelle | SVP, CAO | AWARD | 4,225 | — | — |
| Sep 1, 2026 | van der Berg Andrea Michele | EVP & Chief Financial Officer | AWARD | 6,034 | $106.89 | $645.0K |
| Sep 1, 2026 | van der Berg Andrea Michele | EVP & Chief Financial Officer | AWARD | 1,693 | — | — |
| Sep 1, 2026 | Johnston Joseph Patrick | EVP & President, AW | AWARD | 2,298 | $106.89 | $245.6K |
| Sep 1, 2026 | Johnston Joseph Patrick | EVP & President, AW | AWARD | 645 | — | — |
| Aug 13, 2026 | KOCH D CHRISTIAN | Director | AWARD | 1,247 | $120.27 | $150.0K |
| May 14, 2026 | ELLIS EARL RAY | Director | AWARD | 1,711 | $116.88 | $200.0K |
| May 14, 2026 | FRIEL ROBERT F | Director | AWARD | 2,481 | $116.88 | $290.0K |
| May 14, 2026 | Glatch Lisa | Director | AWARD | 1,711 | $116.88 | $200.0K |
| May 14, 2026 | Harker Victoria D | Director | AWARD | 1,711 | $116.88 | $200.0K |
Congressional trades
XYL trades disclosed by members of Congress, with disclosure delay.
1 members · 3 buys / 0 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Xylem Inc | Aug 12, 2026(37d) |
| Jun 2, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Xylem Inc | Jul 8, 2026(37d) |
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Xylem Inc | May 13, 2026(31d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for XYL.
Shares short
10,897,240
Settlement Sep 15, 2026
Change vs prior
+35.7%
Semi-monthly cycle
Days to cover
3.8
At avg daily volume
Of shares outstanding
≈4.7%
Estimate — not % of float
All XYL filing & press-release reports (6)
- 424B5 reportSep 15, 2026
- 8-K reportJul 28, 2026
- 424B5 reportMay 19, 2026
- CLUSTER reportMay 8, 2026
- DEFA14A reportMar 30, 2026
- 8-K reportFeb 25, 2026